Bain & Company January 8, 2026
Healthcare private equity investment posted a very strong year for deal value and volume, paired with a strong rebound in exits.
At a Glance
- Despite a second-quarter tariff-related pause, global healthcare private equity activity set a record, with more than $190 billion in estimated deal value, while deal volume logged its second-best year ever.
- An uptick in deals exceeding $1 billion drove the record value, but deal counts grew across all deal sizes.
- Exits also surged as sponsor-to-sponsor deals rebounded from post-Covid lows, but public market opportunities remain an active hunting ground for private equity.
- Provider and biopharma remain the largest market segments, driven by healthcare IT activity, while medtech has shown outsized growth since...
Today's Sponsors
Today's Sponsor